Immatics NV (IMTX)
10.30
+0.67
(+6.96%)
USD |
NASDAQ |
Feb 09, 16:00
10.20
-0.10
(-0.97%)
After-Hours: 20:00
Immatics EPS Diluted (Quarterly) : -0.4859 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CureVac NV | 1.414 |
| Bayer AG | -0.2864 |
| MediGene AG | -- |
| InflaRx NV | -0.2115 |
| BioNTech SE | -0.1395 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.06M |
| Revenue (Quarterly) | 6.061M |
| Total Expenses (Quarterly) | 65.13M |
| Enterprise Value | 765.12M |
| Profit Margin (Quarterly) | -974.4% |
| Earnings Yield | -10.62% |
| Normalized Earnings Yield | -11.54 |